Edition:
United States

Immunomedics Inc (IMMU.OQ)

IMMU.OQ on NASDAQ Stock Exchange Global Market

21.17USD
22 May 2018
Change (% chg)

$-0.03 (-0.14%)
Prev Close
$21.20
Open
$21.25
Day's High
$21.45
Day's Low
$21.05
Volume
58,650
Avg. Vol
638,111
52-wk High
$22.50
52-wk Low
$7.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.48 -0.214
Dec 0.60 -0.016
Sep 0.69 -0.811
FY 2017 Jun '17 0.64 -0.485
Mar '17 1.32 -0.550
Dec 0.38 -0.234
Sep 0.74 -0.169
FY 2016 Jun '16 0.93 -0.167
Mar '16 0.90 -0.148
Dec 0.67 -0.145
Sep 0.73 -0.163
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 3.30 3.30 3.30 --
Quarter Ending Mar-18 3 4.27 12.70 0.00 --
Year Ending Jun-18 3 6.03 14.40 1.80 27.05
Year Ending Jun-19 3 41.17 64.80 13.20 53.80
Earnings (per share)
Quarter Ending Dec-18 1 -0.14 -0.14 -0.14 --
Quarter Ending Mar-18 3 -0.15 -0.04 -0.21 --
Year Ending Jun-18 2 -1.09 -0.93 -1.25 -0.49
Year Ending Jun-19 3 -0.74 -0.57 -0.90 -0.91
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 222.84 32.59
P/E High - Last 5 Yrs. -- 281.48 47.07
P/E Low - Last 5 Yrs. -- 95.47 24.59
Beta 1.49 0.75 0.79
Price to Sales (TTM) 1,442.71 262.06 9.01
Price to Book (MRQ) 48.81 23.14 4.24
Price to Tangible Book (MRQ) 47.91 26.27 5.79
Price to Cash Flow (TTM) -- 127.68 21.78
% Owned Institutions 76.18 10.94 2.43

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.66
Dividend Yield - 5 Year Avg 0.00 0.21 0.80
Dividend 5 Year Growth Rate -- 2.35 4.15
Payout Ratio(TTM) -- 46.91 17.73

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -63.56 26.86 5.10
Sales (TTM) vs TTM 1 Yr. Ago -28.68 150.04 12.65
Sales - 5 Yr. Growth Rate -37.62 30.10 8.10
EPS (MRQ) vs Qtr. 1 Yr. Ago 61.08 -158.81 33.25
EPS (TTM) vs TTM 1 Yr. Ago -36.25 -- --
EPS - 5 Yr. Growth Rate -- 46.66 8.54
Capital Spending - 5 Yr. Growth Rate 26.46 38.70 8.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 3.94 1.64 2.50
Current Ratio (MRQ) 3.94 6.54 3.56
LT Debt to Equity (MRQ) 278.04 22.23 12.86
Total Debt to Equity (MRQ) 278.04 25.74 15.83
Interest Coverage (TTM) -12.67 -177.44 35.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.68 33.95 54.64
Gross Margin - 5 Yr. Avg. 85.27 54.86 52.74
EBITD Margin (TTM) -4,732.69 -- --
EBITD - 5 Yr. Avg -950.32 -158.47 15.84
Operating Margin (TTM) -5,322.94 -930.08 -2.34
Operating Margin - 5 Yr. Avg. -900.69 -171.29 11.09
Pre-Tax Margin (TTM) -8,711.01 -814.97 -0.23
Pre-Tax Margin - 5 Yr. Avg. -1,202.66 -176.85 11.29
Net Profit Margin (TTM) -8,711.87 -806.24 -3.64
Net Profit Margin - 5 Yr. Avg. -1,183.71 -176.13 7.58
Effective Tax Rate (TTM) -- 14.58 31.25
Effective Tax Rate - 5 Yr. Avg. -- 18.23 24.61

Efficiency

  Company industry sector
Revenue/Employee (TTM) 17,477 21,442,083 721,262,098
Net Income/Employee (TTM) -1,522,583 -1,504,037 83,813,821
Receivable Turnover (TTM) 4.75 16.37 5.67
Inventory Turnover (TTM) 1.92 2.46 3.55
Asset Turnover (TTM) 0.01 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -97.15 -5.46 9.98
Return on Assets - 5 Yr. Avg. -85.73 -0.52 11.07
Return on Investment (TTM) -164.45 -7.75 12.60
Return on Investment - 5 Yr. Avg. -119.48 2.72 14.34
Return on Equity (TTM) -- -10.55 14.49
Return on Equity - 5 Yr. Avg. -4,597.47 -2.70 15.71
  1 Year 3 Year 5 Year
Sales % -4.39 -30.08 -37.62
EPS (TTM) % -135.27 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Immunomedics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 31.35 28.34 99 40
13 Week 28.72 28.68 99 45
26 Week 83.07 72.97 99 84
52 Week 188.44 151.36 99 83
YTD 31.19 28.34 99 81
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 76.18%
# of Holders: 233
Total Shares Held: 127,484,776
3 Mo. Net Change: 1,065,579
# New Positions: 35
# Closed Positions: 19
# Increased Positions: 113
# Reduced Positions: 87
# Net Buyers: 26
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.